Express News | Bio-Techne Corp : RBC Raises Target Price to $77 From $70
Here's What Dragged Bio-Techne Corporation (TECH)?
Bio-Techne To Present At 2024 Wells Fargo Healthcare Conference; Webcast At 11:00 AM ET
BofA's Global Contenders and Defenders List
Some Investors May Be Willing To Look Past Bio-Techne's (NASDAQ:TECH) Soft Earnings
Baird Maintains Bio-Techne(TECH.US) With Buy Rating, Maintains Target Price $82
Baird analyst Catherine Ramsey Schulte maintains $Bio-Techne(TECH.US)$ with a buy rating, and maintains the target price at $82.According to TipRanks data, the analyst has a success rate of 56.0%